Financials Sewoon Medical Co., Ltd

Equities

A100700

KR7100700004

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
2,770 KRW +0.73% Intraday chart for Sewoon Medical Co., Ltd +3.55% -3.15%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 163,207 139,614 272,301 179,875 126,410 123,813
Enterprise Value (EV) 1 147,816 119,914 238,625 128,832 70,449 48,884
P/E ratio 16.9 x 14.7 x 25.9 x 14.6 x 12.1 x 8.29 x
Yield 1.33% 1.55% 0.79% 1.2% 2.05% -
Capitalization / Revenue 2.54 x 2.09 x 4.27 x 2.87 x 2.1 x 1.81 x
EV / Revenue 2.3 x 1.79 x 3.74 x 2.06 x 1.17 x 0.72 x
EV / EBITDA 8.75 x 5.88 x 13.6 x 6.7 x 4.38 x 2.38 x
EV / FCF 28.5 x 14.6 x 17.8 x 7.97 x 17.1 x 2.99 x
FCF Yield 3.5% 6.83% 5.62% 12.5% 5.84% 33.4%
Price to Book 1.89 x 1.47 x 2.67 x 1.58 x 1.03 x 0.92 x
Nbr of stocks (in thousands) 43,291 43,291 43,291 43,291 43,291 43,291
Reference price 2 3,770 3,225 6,290 4,155 2,920 2,860
Announcement Date 3/21/19 3/16/20 3/19/21 3/23/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 64,286 66,869 63,729 62,579 60,116 68,247
EBITDA 1 16,886 20,405 17,581 19,222 16,075 20,568
EBIT 1 13,768 16,908 13,897 15,386 12,187 16,920
Operating Margin 21.42% 25.29% 21.81% 24.59% 20.27% 24.79%
Earnings before Tax (EBT) 1 14,291 17,231 13,337 16,626 13,629 19,298
Net income 1 9,672 9,476 10,496 12,282 10,406 14,957
Net margin 15.05% 14.17% 16.47% 19.63% 17.31% 21.92%
EPS 2 223.4 218.9 242.4 283.7 240.4 345.0
Free Cash Flow 1 5,178 8,195 13,411 16,161 4,115 16,336
FCF margin 8.05% 12.26% 21.04% 25.82% 6.84% 23.94%
FCF Conversion (EBITDA) 30.66% 40.16% 76.28% 84.07% 25.6% 79.42%
FCF Conversion (Net income) 53.53% 86.49% 127.78% 131.59% 39.54% 109.22%
Dividend per Share 2 50.00 50.00 50.00 50.00 60.00 -
Announcement Date 3/21/19 3/16/20 3/19/21 3/23/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 15,391 19,699 33,676 51,042 55,961 74,929
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 5,178 8,195 13,411 16,161 4,115 16,336
ROE (net income / shareholders' equity) 12.1% 15.7% 10.6% 11.6% 8.83% 11.8%
ROA (Net income/ Total Assets) 9.41% 10.5% 8.12% 8.21% 5.92% 7.58%
Assets 1 102,816 90,274 129,297 149,588 175,701 197,368
Book Value Per Share 2 1,995 2,199 2,356 2,636 2,841 3,104
Cash Flow per Share 2 407.0 470.0 800.0 1,036 739.0 1,739
Capex 1 5,414 5,934 2,274 2,224 2,151 1,949
Capex / Sales 8.42% 8.87% 3.57% 3.55% 3.58% 2.86%
Announcement Date 3/21/19 3/16/20 3/19/21 3/23/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A100700 Stock
  4. Financials Sewoon Medical Co., Ltd